Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Sars-cov-2 symbols : LMDX save search
LumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete and LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete
Published: 2022-06-08 (Crawled : 11:00) - biospace.com/
LMDX | $0.016 -15.0% 130M
|
|
| O: 3.35%
H: 12.22%
C: 6.73%
star sars-cov-2
LumiraDx Receives WHO Emergency Use Listing for SARS-CoV-2 Ag Test
Published: 2022-05-20 (Crawled : 10:00) - biospace.com/
LMDX | $0.016 -15.0% 130M
|
|
| O: -2.81%
H: 3.95%
C: 1.84%
test sars-cov-2
LumiraDx Fast Lab Solutions Partners with Audere for At-Home Self- Collection Solution for use with SARS-CoV-2 RNA STAR Complete
Published: 2021-12-15 (Crawled : 15:00) - biospace.com/
LMDX | $0.016 -15.0% 130M
|
|
| O: -0.85%
H: 11.78%
C: 11.17%
sars-cov-2
FDA Reissues LumiraDx Fast Lab Solutions' EUA for SARS CoV-2 RNA STAR Complete Molecular Reagents to Allow High Throughput and Asymptomatic Testing Solutions
Published: 2021-12-01 (Crawled : 14:30) - biospace.com/
LMDX | $0.016 -15.0% 130M
|
|
| O: 8.54%
H: 3.01%
C: -7.67%
fda test molecular sars-cov-2
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.